Concepedia

Marijo Bilušić

MB

Statistics

Publications

46

Citations

2.9K

H-Index

24

Active since

2004

Affiliations

National Cancer Institute(Current)

National Institutes of Health

Center for Cancer Research

Fox Chase Cancer Center

Temple University Health System

Marijo Bilušić is an author at National Cancer Institute specializing in medicine, oncology, and cancer immunotherapy.

Publications per year

2004–2023

46

Publications

46

Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer

Elizabeth R. Plimack, Roland L. Dunbrack, Timothy Brennan et al. · European Urology · 2015 · 541 citations · Full text

Medicine, Oncology, Urology +13

Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations

Fatima Karzai, David James VanderWeele, Ravi A. Madan et al. · Journal for ImmunoTherapy of Cancer · 2018 · 312 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase I trial of HuMax-IL8 (BMS-986253), an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumors

Marijo Bilušić, Christopher R. Heery, Julie Collins et al. · Journal for ImmunoTherapy of Cancer · 2019 · 273 citations · Full text

Medicine, Oncology, Pharmacology +17

First-in-Human Phase I Trial of a Tumor-Targeted Cytokine (NHS-IL12) in Subjects with Metastatic Solid Tumors

Julius Strauss, Christopher R. Heery, Joseph W. Kim et al. · Clinical Cancer Research · 2018 · 171 citations · Full text

Medicine, Oncology, Pharmacology +17

Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies

Julius Strauss, Margaret E. Gatti‐Mays, Byoung Chul Cho et al. · Journal for ImmunoTherapy of Cancer · 2020 · 159 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 46